SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094004
Filing Date
2024-08-08
Accepted
2024-08-08 16:15:37
Documents
74
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lctx-20240630.htm   iXBRL 10-Q 2065089
2 EX-10.1 lctx-ex10_1.htm EX-10.1 418375
3 EX-31.1 lctx-ex31_1.htm EX-31.1 13906
4 EX-31.2 lctx-ex31_2.htm EX-31.2 12645
5 EX-32.1 lctx-ex32_1.htm EX-32.1 9571
  Complete submission text file 0000950170-24-094004.txt   9412814

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lctx-20240630.xsd EX-101.SCH 1301709
76 EXTRACTED XBRL INSTANCE DOCUMENT lctx-20240630_htm.xml XML 1549677
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 241188567
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)